Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00937794 · ClinicalTrials.gov registry record
Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®
A clinical trial, sponsored by Shire.
- Completed
- Registry status
- 33
- Enrollment target
NCT00937794 is a clinical trial that has completed, run by Shire. The registered enrollment target is 33 participants.
The verdict
NCT00937794 has completed, sponsored by Shire.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
This study is being conducted to identify pediatric patients with Hunter syndrome who have neurodevelopmental disease characteristics, who are currently receiving treatment with Elaprase, and who may be suitable to participate in a clinical study with an investigational agent.
Interventions
- BEHAVIORAL Neurobehavioral testing
- OTHER Visual and auditory assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2009-07-02 |
| Est. Completion | 2011-07-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00937794
The ClinicalTrials.gov registry entry for NCT00937794 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neurobehavioral testing is the first listed.
NCT00937794 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00937794 about?
NCT00937794 is a clinical study titled "Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®". This study is being conducted to identify pediatric patients with Hunter syndrome who have neurodevelopmental disease characteristics, who are currently receiving treatment with Elaprase, and who may be suitable to participate in a clinical study with an investigational agent.
What is the current status of trial NCT00937794?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2009-07-02. Estimated completion is 2011-07-13.
What interventions are being tested in trial NCT00937794?
The interventions under investigation include: Neurobehavioral testing (BEHAVIORAL), Visual and auditory assessments (OTHER).
Who is sponsoring clinical trial NCT00937794?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.